SloMo2: Implementation, Effectiveness, and Cost-effectiveness Study

NARecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

October 16, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

September 1, 2026

Conditions
Schizophrenia Spectrum and Other Psychotic DisordersAffective Psychoses
Interventions
OTHER

SloMo

SloMo, is a blended digital therapeutic for people who fear harm from others. It is based on cognitive-behavioural therapy for psychosis. An online therapy platform supports the delivery of 11 face-to-face sessions, which are synchronised to a native mobile app for use in daily life. SloMo works by helping people to notice their worries and fast thinking habits, and encourages them to slow down for a moment to find ways of feeling safer.

Trial Locations (1)

Unknown

RECRUITING

South London and Maudsley NHS Foundation Trust, London

All Listed Sponsors
collaborator

South London and Maudsley NHS Foundation Trust

OTHER

collaborator

Sussex Partnership NHS Foundation Trust

OTHER

collaborator

Northumberland, Tyne and Wear NHS Foundation Trust

OTHER

lead

King's College London

OTHER